Coral Partners with DrugViu to Address Minority Representation in Autoimmune Precision Medicine Initiative

Coral, a San Francisco biotech developing new clinical tests to improve medication selection and market access for autoimmune patients has partnered with DrugViu, a healthcare technology company that helps patients with autoimmune diseases get full control and consolidate their medical records to find better treatment options, participate in clinical trials and track their contributions to research.